Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Dexmedetomidine Versus Chloral Hydrate for Pediatric Sedation During EEG

This study has been withdrawn prior to enrollment.
(Unable to obtain approval from FDA for use of chloral hydrate)
Sponsor:
Collaborator:
Hospira, Inc.
Information provided by:
Wesley Medical Center
ClinicalTrials.gov Identifier:
NCT00464451
First received: April 19, 2007
Last updated: January 13, 2010
Last verified: January 2010
No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
  Study Status: This study has been withdrawn prior to enrollment.
  Estimated Study Completion Date: May 2011
  Estimated Primary Completion Date: December 2010 (Final data collection date for primary outcome measure)